GeneralConnection.com ➔ Dictionary
Dictionary Search

pharmaceutics

Synonyms

Noun

1. pharmacy

2. medicine, medical specialty

Usage
Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market - PR Newswire
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - BioSpace
Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST) - Seeking Alpha
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? - The Motley Fool
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study - smallcaps.com.au
Biogen completes acquisition of Apellis Pharmaceuticals - Ophthalmology Times
Xenon Pharmaceuticals Inc. Rings the Opening Bell - Nasdaq
Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards? - Yahoo Finance
Biogen Completes Acquisition of Apellis Pharmaceuticals - Biogen
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company - investor.lilly.com
Trump imposes tariffs on pharmaceuticals, adjusts duties on steel, other metals - Politico
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million - The Motley Fool
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem - PR Newswire
Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts - Yahoo Finance
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - PR Newswire
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger - PR Newswire
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting - PR Newswire
NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies - PR Newswire
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 - PR Newswire
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results - PR Newswire
EPA flags microplastics, pharmaceuticals as contaminants in drinking water - NPR
Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development - ACS Publications
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors - PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results - PR Newswire
Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe - Arrowhead Pharmaceuticals, Inc.
A Novel Immune-Modulating Nanodrug Enhances Liver-Targeted mRNA Delivery - ACS Publications
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results - PR Newswire
Kezar Life Sciences Acquired by Aurinia Pharmaceuticals - Cooley
EPA’s Draft Sixth Contaminant Candidate List Targets Microplastics and Pharmaceuticals in Drinking Water - globalelr.com
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - PR Newswire
EPA Begins Process to Regulate Pharmaceuticals in Drinking Water - insideenergyandenvironment.com
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs - PR Newswire
Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" - PR Newswire
EPA adds microplastics, pharmaceuticals to contaminant list - Coastal Review
NLS Pharmaceutics and Kadimastem merge to form NewcelX - S-GE
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
Pharmaceuticals in the Environment - UNEP - UN Environment Programme
Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures - Interpol
Estimating US savings on outpatient prescription pharmaceuticals from international reference pricing - PNAS
Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) - PR Newswire
Executive Order Imposing Section 232 Tariffs on Pharmaceuticals and Pharmaceutical Ingredients - Foley Hoag
Drawing inspiration from nature to formulate new pharmaceuticals - Purdue University - College of Agriculture
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire
EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water - The Guardian
Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? - The Motley Fool
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire
Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform - Sixth Street
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods - PR Newswire
US agencies to monitor drinking water for microplastics, pharmaceuticals - Reuters
PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION - PR Newswire
Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years - PR Newswire
Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville - Wake County Government (.gov)
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire
A Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name Pharmaceuticals - Jones Day
Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.
How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting As Analyst Targets Reset - Yahoo Finance
Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 - PR Newswire
Enzian Pharmaceutics demonstrates that its expandable fibrous dosage forms enhance the bioavailability of sparingly-soluble drugs - Business Wire
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Ironwood Pharmaceuticals
EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water - AP News
A Look At Recursion Pharmaceuticals (RXRX) Valuation After Clinical Updates And FDA Discussions - Yahoo Finance
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - PR Newswire
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Business Wire
[Hikma Pharmaceuticals v. Amarin Pharma] Oral Argument - C-SPAN
Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) - PR Newswire
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ - PR Newswire
Is Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen? - Yahoo Finance
Acadia Pharmaceuticals Rings the Opening Bell - Nasdaq
Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now - Yahoo Finance
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress - Business Wire
Press release titled: “Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger.” - SEC.gov
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events - Business Wire
Merck to buy Terns Pharmaceuticals in $6.7B deal - statnews.com
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation - PR Newswire
Akin Advises Pharmakon in $100 Million Debt Financing for Paratek Pharmaceuticals and Radius Health Combination - Akin
Alebund Pharmaceuticals Announces License and Equity Agreements With R1 Therapeutics - Cooley
Is Catalyst Pharmaceuticals (CPRX) Still Attractively Priced After Recent Share Price Stability? - Yahoo Finance
Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis - Business Wire
Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio - CNBC
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA - Dermatology Times
Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics - PR Newswire
Afinum Invests in Formulation Development Specialist ProJect Pharmaceutics - orrick.com
US imposes new Section 232 tariffs on pharmaceuticals and revises tariffs on aluminum, steel, and copper - PwC
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026 - Business Wire
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies - ACS Publications
Qubit Pharmaceuticals to Collaborate with the Centre for Quantum Technologies in Singapore to Advance Quantum Algorithms for Drug Discovery - The Quantum Insider
Mintz Advises on Eupraxia Pharmaceuticals $63.2 Million Public Offering - Mintz
Trump administration announces new tariffs on pharmaceuticals - Financial Times
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire
Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results - Arrowhead Pharmaceuticals, Inc.
Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Extending Firdapse Exclusivity And Launching Agamree - Has The Bull Case Changed? - Yahoo Finance
Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money - Yahoo Finance
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals - Business Wire
Small Activating RNAs: Delivery and Therapeutic Applications in Disease Treatment - ACS Publications
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PR Newswire
Swiss industry body says US tariffs on pharmaceuticals will harm patients - Reuters
Foreign Language Equivalents
Foreign Language Equivalents of 'pharmaceutics'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
pjarmaceutics,   pharmaceytics,   pharmaceitics,   pharmaeutics,   ppharmaceutics,   harmaceutics,   pharmacetics,   pharmaceutis,   pharaceutics,   pharmacetuics,   pharmceutics,   pharmaceuttics,   pharmaecutics,   pharmsceutics,   pharmaceutcis,   pharmaceutixs,   pharmacwutics,   phatmaceutics,   pharmaceuitcs,   pharmacutics,   pharmaceuyics,   pharnaceutics,   phramaceutics,   pharmaceutivs,   pharmaaceutics,   pharmaxeutics,   pharmaceuticcs,   pharmacceutics,   phrmaceutics,   pahrmaceutics,   parmaceutics,   hparmaceutics,   pharmmaceutics,   oharmaceutics,   pgarmaceutics,   phamraceutics,   pharmaceurics,   pharamceutics,   pharmacrutics,   pharmaceutica,   pharmaceuutics,   pharmaceuticss,   pharmaceuticd,   pharmcaeutics,   pharrmaceutics,   phamaceutics,   pharmaceuics,   phaemaceutics,   pharmaceutcs,   [harmaceutics,   phharmaceutics,   pharmaceutucs,   pharmaceutic,   pharmaveutics,   pharmaceeutics,   phaarmaceutics,   pharmaceutisc,   phar,aceutics,   pharmacuetics,   pharmaceutiics,   phsrmaceutics,   pharmaceutocs
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z